Pfizer Sells Off After Discontinuing Weight Loss Drug - The Wall Street Journal
- Pfizer Sells Off After Discontinuing Weight Loss Drug The Wall Street Journal
- Pfizer scraps one weight loss drug in race to develop Ozempic rival Yahoo! Voices
- Pfizer Stock Tumbles On 'A Big Setback' In Obesity Treatment Investor's Business Daily
- In setback, Pfizer abandons one weight-loss pill and bets on another STAT
- Pfizer stock drops as it ends development of Ozempic rival Yahoo Finance
- View Full Coverage on Google News